Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 656

1.

Myeloperoxidase is a potential molecular imaging and therapeutic target for the identification and stabilization of high-risk atherosclerotic plaque.

Rashid I, Maghzal GJ, Chen YC, Cheng D, Talib J, Newington D, Ren M, Vajandar SK, Searle A, Maluenda A, Lindstedt EL, Jabbour A, Kettle AJ, Bongers A, Power C, Michaëlsson E, Peter K, Stocker R.

Eur Heart J. 2018 Sep 14;39(35):3301-3310. doi: 10.1093/eurheartj/ehy419.

PMID:
30219874
2.

Using High-Resolution Mass Spectrometry to Identify Organic Contaminants Linked to Urban Stormwater Mortality Syndrome in Coho Salmon.

Peter KT, Tian Z, Wu C, Lin P, White S, Du B, McIntyre JK, Scholz NL, Kolodziej EP.

Environ Sci Technol. 2018 Sep 18;52(18):10317-10327. doi: 10.1021/acs.est.8b03287. Epub 2018 Sep 7.

PMID:
30192129
3.

Double genetic disruption of lactate dehydrogenase A and B is required to ablate the 'Warburg effect' restricting tumor growth to oxidative metabolism.

Ždralević M, Brand A, Di Ianni L, Dettmer K, Reinders J, Singer K, Peter K, Schnell A, Bruss C, Decking SM, Koehl G, Felipe-Abrio B, Durivault J, Bayer P, Evangelista M, O'Brien T, Oefner PJ, Renner K, Pouysségur J, Kreutz M.

J Biol Chem. 2018 Aug 29. pii: jbc.RA118.004180. doi: 10.1074/jbc.RA118.004180. [Epub ahead of print]

4.

The bidirectional interaction between the Sympathetic Nervous System and Immune mechanisms in the pathogenesis of hypertension.

Carnagarin R, Matthews V, Zaldivia MTK, Peter K, Schlaich MP.

Br J Pharmacol. 2018 Aug 20. doi: 10.1111/bph.14481. [Epub ahead of print] Review.

PMID:
30129037
5.

Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis.

Hanjaya-Putra D, Haller C, Wang X, Dai E, Lim B, Liu L, Jaminet P, Yao J, Searle A, Bonnard T, Hagemeyer CE, Peter K, Chaikof EL.

JCI Insight. 2018 Aug 9;3(15). pii: 99329. doi: 10.1172/jci.insight.99329. [Epub ahead of print]

6.

Platelet lipidomics and function: joining the dots.

McFadyen JD, Peter K.

Blood. 2018 Aug 2;132(5):465-466. doi: 10.1182/blood-2018-06-854950. No abstract available.

PMID:
30072414
7.

The pulmonary microvasculature entraps induced vascular progenitor cells (iVPCs) systemically delivered after cardiac ischemia-reperfusion injury: Indication for preservation of heart function via paracrine effects beyond engraftment.

Ziegler M, Haigh K, Nguyen T, Wang X, Lim B, Yap ML, Eddy EM, Haigh JJ, Peter K.

Microcirculation. 2018 Jul 21:e12493. doi: 10.1111/micc.12493. [Epub ahead of print]

PMID:
30030876
8.

Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes.

McFadyen JD, Kiefer J, Braig D, Loseff-Silver J, Potempa LA, Eisenhardt SU, Peter K.

Front Immunol. 2018 Jun 12;9:1351. doi: 10.3389/fimmu.2018.01351. eCollection 2018. Review.

9.

Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.

Hosseini H, Yi L, Kanellakis P, Cao A, Tay C, Peter K, Bobik A, Toh BH, Kyaw T.

J Am Heart Assoc. 2018 Jun 23;7(13). pii: e008447. doi: 10.1161/JAHA.117.008447.

10.

Can Predictive Modeling Identify Head and Neck Oncology Patients at Risk for Readmission?

Manning AM, Casper KA, Peter KS, Wilson KM, Mark JR, Collar RM.

Otolaryngol Head Neck Surg. 2018 May 1:194599818775938. doi: 10.1177/0194599818775938. [Epub ahead of print]

PMID:
29783911
11.

The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.

Diehl P, Gaul DS, Sogl J, Flierl U, Henstridge D, Pahla J, Bugger H, Emmert MY, Ruschitzka F, Bode C, Lüscher TF, Moser M, Matter CM, Peter K, Winnik S.

J Thromb Thrombolysis. 2018 Jul;46(1):102-112. doi: 10.1007/s11239-018-1677-3.

PMID:
29774488
12.

Characterization of a new apple luteovirus identified by high-throughput sequencing.

Liu H, Wu L, Nikolaeva E, Peter K, Liu Z, Mollov D, Cao M, Li R.

Virol J. 2018 May 15;15(1):85. doi: 10.1186/s12985-018-0998-3.

13.

Platelets Drive Inflammation and Target Gray Matter and the Retina in Autoimmune-Mediated Encephalomyelitis.

Sonia D'Souza C, Li Z, Luke Maxwell D, Trusler O, Murphy M, Crewther S, Peter K, Orian JM.

J Neuropathol Exp Neurol. 2018 Jul 1;77(7):567-576. doi: 10.1093/jnen/nly032.

PMID:
29757405
14.

A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.

Thiele JR, Zeller J, Kiefer J, Braig D, Kreuzaler S, Lenz Y, Potempa LA, Grahammer F, Huber TB, Huber-Lang M, Bannasch H, Stark GB, Peter K, Eisenhardt SU.

Front Immunol. 2018 Apr 16;9:675. doi: 10.3389/fimmu.2018.00675. eCollection 2018.

15.

Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development.

Wang X, Searle AK, Hohmann JD, Liu AL, Abraham MK, Palasubramaniam J, Lim B, Yao Y, Wallert M, Yu E, Chen YC, Peter K.

Mol Ther. 2018 Apr 4;26(4):1056-1065. doi: 10.1016/j.ymthe.2018.02.010. Epub 2018 Feb 16.

16.

Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction.

Robinson S, Follo M, Haenel D, Mauler M, Stallmann D, Tewari M, Duerschmied D, Peter K, Bode C, Ahrens I, Hortmann M.

Int J Cardiol. 2018 Apr 15;257:247-254. doi: 10.1016/j.ijcard.2017.10.111.

PMID:
29506703
17.

Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation.

Sata Y, Hering D, Head GA, Walton AS, Peter K, Marusic P, Duval J, Lee R, Hammond LJ, Lambert EA, Lambert GW, Esler MD, Schlaich MP.

J Hypertens. 2018 Jun;36(6):1414-1422. doi: 10.1097/HJH.0000000000001682.

PMID:
29465712
18.

A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.

Wolf D, Anto-Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann JD, Lim B, Bäuml M, Marki A, Mauler M, Duerschmied D, Fan Z, Winkels H, Sidler D, Diehl P, Zajonc DM, Hilgendorf I, Stachon P, Marchini T, Willecke F, Schell M, Sommer B, von Zur Muhlen C, Reinöhl J, Gerhardt T, Plow EF, Yakubenko V, Libby P, Bode C, Ley K, Peter K, Zirlik A.

Nat Commun. 2018 Feb 6;9(1):525. doi: 10.1038/s41467-018-02896-8.

19.

Current and future antiplatelet therapies: emphasis on preserving haemostasis.

McFadyen JD, Schaff M, Peter K.

Nat Rev Cardiol. 2018 Mar;15(3):181-191. doi: 10.1038/nrcardio.2017.206. Epub 2018 Jan 3. Review.

PMID:
29297508
20.

An Erwinia amylovora yjeK mutant exhibits reduced virulence, increased chemical sensitivity and numerous environmentally dependent proteomic alterations.

Klee SM, Mostafa I, Chen S, Dufresne C, Lehman BL, Sinn JP, Peter KA, McNellis TW.

Mol Plant Pathol. 2018 Jul;19(7):1667-1678. doi: 10.1111/mpp.12650. Epub 2018 Feb 1.

PMID:
29232043
21.

Platelet-Derived Microvesicles in Cardiovascular Diseases.

Zaldivia MTK, McFadyen JD, Lim B, Wang X, Peter K.

Front Cardiovasc Med. 2017 Nov 21;4:74. doi: 10.3389/fcvm.2017.00074. eCollection 2017. Review.

22.

Chip-based digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction patients.

Robinson S, Follo M, Haenel D, Mauler M, Stallmann D, Heger LA, Helbing T, Duerschmied D, Peter K, Bode C, Ahrens I, Hortmann M.

Acta Pharmacol Sin. 2018 Jul;39(7):1217-1227. doi: 10.1038/aps.2017.136. Epub 2017 Nov 30.

PMID:
29188800
23.

Mesoscale Nanoparticles: An Unexpected Means for Selective Therapeutic Targeting of Kidney Diseases!

Yap ML, Wang X, Pietersz GA, Peter K.

Hypertension. 2018 Jan;71(1):61-63. doi: 10.1161/HYPERTENSIONAHA.117.09944. Epub 2017 Nov 13. No abstract available.

PMID:
29133359
24.

Circulating HtrA2 after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A potential novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury.

Hortmann M, Robinson S, Mohr M, Haenel D, Mauler M, Laumann R, Stallmann D, Reinoehl J, Duerschmied D, Peter K, Bode C, Ahrens I.

Int J Cardiol. 2017 Dec 15;249:437. doi: 10.1016/j.ijcard.2017.08.022. No abstract available.

PMID:
29121749
25.

CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages.

Samudra AN, Dwyer KM, Selan C, Freddi S, Murray-Segal L, Nikpour M, Hickey MJ, Peter K, Robson SC, Sashindranath M, Cowan PJ, Nandurkar HH.

J Autoimmun. 2018 Mar;88:131-138. doi: 10.1016/j.jaut.2017.10.009. Epub 2017 Nov 3.

PMID:
29103803
26.

A molecular intravascular ultrasound contrast agent allows detection of activated platelets on the surface of symptomatic human plaques.

Maier A, Plaza-Heck P, Meixner F, Guenther F, Kaufmann BA, Kramer M, Heidt T, Zirlik A, Hilgendorf I, Reinöhl J, Stachon P, Bronsert P, Birkemeyer R, Neudorfer I, Peter K, Bode C, von Zur Mühlen C.

Atherosclerosis. 2017 Dec;267:68-77. doi: 10.1016/j.atherosclerosis.2017.10.029. Epub 2017 Oct 24.

PMID:
29101838
27.

Indoxyl 3-sulfate inhibits maturation and activation of human monocyte-derived dendritic cells.

Ghimire S, Matos C, Caioni M, Weber D, Peter K, Holler E, Kreutz M, Renner K.

Immunobiology. 2018 Feb;223(2):239-245. doi: 10.1016/j.imbio.2017.10.014. Epub 2017 Oct 6.

PMID:
29100619
28.

Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis.

Günther F, Heidt T, Kramer M, Khanicheh E, Klibanov AL, Geibel-Zehender A, Ferrante EA, Hilgendorf I, Wolf D, Zirlik A, Reinöhl J, Bode C, Peter K, Kaufmann BA, Mühlen CVZ.

Sci Rep. 2017 Nov 2;7(1):14898. doi: 10.1038/s41598-017-15080-7.

29.

Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.

McFadyen JD, Peter K.

Circ Res. 2017 Oct 27;121(10):1133-1135. doi: 10.1161/CIRCRESAHA.117.312012. No abstract available.

PMID:
29074533
30.

Nanoliposomes for Safe and Efficient Therapeutic mRNA Delivery: A Step Toward Nanotheranostics in Inflammatory and Cardiovascular Diseases as well as Cancer.

Abraham MK, Peter K, Michel T, Wendel HP, Krajewski S, Wang X.

Nanotheranostics. 2017 Apr 5;1(2):154-165. doi: 10.7150/ntno.19449. eCollection 2017.

31.

Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment.

Flierl U, Nero TL, Lim B, Andrews RK, Parker MW, Gardiner EE, Peter K.

J Thromb Haemost. 2018 Jan;16(1):181-185. doi: 10.1111/jth.13877. Epub 2017 Nov 16. No abstract available.

PMID:
29052937
32.

Mast Cell: An Unexpected Villain in Venous Thromboembolism?

Huang AL, Bosco JJ, Peter K.

Circ Res. 2017 Sep 29;121(8):899-901. doi: 10.1161/CIRCRESAHA.117.311777. No abstract available.

PMID:
28963183
33.

The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.

Weber D, Frauenschläger K, Ghimire S, Peter K, Panzer I, Hiergeist A, Weber M, Kutny D, Wolff D, Grube M, Huber E, Oefner P, Gessner A, Hehlgans T, Herr W, Holler E.

PLoS One. 2017 Sep 21;12(9):e0185265. doi: 10.1371/journal.pone.0185265. eCollection 2017.

34.

Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications.

Michel T, Luft D, Abraham MK, Reinhardt S, Salinas Medina ML, Kurz J, Schaller M, Avci-Adali M, Schlensak C, Peter K, Wendel HP, Wang X, Krajewski S.

Mol Ther Nucleic Acids. 2017 Sep 15;8:459-468. doi: 10.1016/j.omtn.2017.07.013. Epub 2017 Jul 25.

35.

Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury.

Ziegler M, Wang X, Lim B, Leitner E, Klingberg F, Ching V, Yao Y, Huang D, Gao XM, Kiriazis H, Du XJ, Haigh JJ, Bobik A, Hagemeyer CE, Ahrens I, Peter K.

Theranostics. 2017 Jul 22;7(13):3192-3206. doi: 10.7150/thno.19698. eCollection 2017.

36.

GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes.

Ying YL, Chen YC, Jandeleit-Dahm K, Peter K.

Atherosclerosis. 2017 Oct;265:250-252. doi: 10.1016/j.atherosclerosis.2017.08.006. Epub 2017 Aug 18. No abstract available.

PMID:
28870630
37.

Development of suspect and non-target screening methods for detection of organic contaminants in highway runoff and fish tissue with high-resolution time-of-flight mass spectrometry.

Du B, Lofton JM, Peter KT, Gipe AD, James CA, McIntyre JK, Scholz NL, Baker JE, Kolodziej EP.

Environ Sci Process Impacts. 2017 Sep 20;19(9):1185-1196. doi: 10.1039/c7em00243b.

PMID:
28825428
38.

Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging.

Yap ML, McFadyen JD, Wang X, Zia NA, Hohmann JD, Ziegler M, Yao Y, Pham A, Harris M, Donnelly PS, Hogarth PM, Pietersz GA, Lim B, Peter K.

Theranostics. 2017 Jun 25;7(10):2565-2574. doi: 10.7150/thno.19900. eCollection 2017.

39.

Molecular Sensors of Blood Flow in Endothelial Cells.

Baratchi S, Khoshmanesh K, Woodman OL, Potocnik S, Peter K, McIntyre P.

Trends Mol Med. 2017 Sep;23(9):850-868. doi: 10.1016/j.molmed.2017.07.007. Epub 2017 Aug 12. Review.

PMID:
28811171
40.

Near-infrared autofluorescence induced by intraplaque hemorrhage and heme degradation as marker for high-risk atherosclerotic plaques.

Htun NM, Chen YC, Lim B, Schiller T, Maghzal GJ, Huang AL, Elgass KD, Rivera J, Schneider HG, Wood BR, Stocker R, Peter K.

Nat Commun. 2017 Jul 13;8(1):75. doi: 10.1038/s41467-017-00138-x.

41.

Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.

Pietersz GA, Wang X, Yap ML, Lim B, Peter K.

Nanomedicine (Lond). 2017 Aug;12(15):1873-1889. doi: 10.2217/nnm-2017-0043. Epub 2017 Jul 13. Review.

42.

Nurse managers: Determinants and behaviours in relation to patient and visitor aggression in general hospitals. A qualitative study.

Heckemann B, Peter KA, Halfens RJ, Schols JM, Kok G, Hahn S.

J Adv Nurs. 2017 Dec;73(12):3050-3060. doi: 10.1111/jan.13366. Epub 2017 Jul 16.

PMID:
28637091
43.

Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.

Hortmann M, Robinson S, Mohr M, Haenel D, Mauler M, Stallmann D, Reinoehl J, Duerschmied D, Peter K, Bode C, Ahrens I.

Int J Cardiol. 2017 Sep 15;243:485-491. doi: 10.1016/j.ijcard.2017.05.088. Epub 2017 May 24.

PMID:
28602551
44.

Platelet receptors as therapeutic targets: Past, present and future.

Jamasbi J, Ayabe K, Goto S, Nieswandt B, Peter K, Siess W.

Thromb Haemost. 2017 Jun 28;117(7):1249-1257. doi: 10.1160/TH16-12-0911. Epub 2017 Jun 9. Review.

PMID:
28597906
45.

The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction.

Hortmann M, Robinson S, Mohr M, Mauler M, Stallmann D, Reinöhl J, Duerschmied D, Peter K, Carr J, Gibson CM, Bode C, Ahrens I.

Eur Heart J Acute Cardiovasc Care. 2017 May 1:2048872617710789. doi: 10.1177/2048872617710789. [Epub ahead of print]

PMID:
28534645
46.

Platelet lipidomics: a window of opportunity to assess cardiovascular risk?

McFadyen JD, Meikle PJ, Peter K.

Eur Heart J. 2017 Jul 1;38(25):2006-2008. doi: 10.1093/eurheartj/ehx258. No abstract available.

PMID:
28520938
47.

A single-chain antibody-CD39 fusion protein targeting activated platelets protects from cardiac ischaemia/reperfusion injury.

Ziegler M, Hohmann JD, Searle AK, Abraham MK, Nandurkar HH, Wang X, Peter K.

Eur Heart J. 2018 Jan 7;39(2):111-116. doi: 10.1093/eurheartj/ehx218.

PMID:
28472483
48.

Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Kyaw T, Peter K, Li Y, Tipping P, Toh BH, Bobik A.

Br J Pharmacol. 2017 Nov;174(22):3956-3972. doi: 10.1111/bph.13845. Epub 2017 Jun 13. Review.

PMID:
28471481
49.

Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.

Ta HT, Li Z, Hagemeyer CE, Cowin G, Zhang S, Palasubramaniam J, Alt K, Wang X, Peter K, Whittaker AK.

Biomaterials. 2017 Jul;134:31-42. doi: 10.1016/j.biomaterials.2017.04.037. Epub 2017 Apr 22.

PMID:
28453956
50.

Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.

Wang X, Peter K.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1029-1040. doi: 10.1161/ATVBAHA.116.306483. Epub 2017 Apr 27. Review.

PMID:
28450298

Supplemental Content

Support Center